In a recent transaction, Kathleen Kool, a director at Aspen Aerogels Inc (NYSE:ASPN), sold shares of the company's stock, generating over $122,000 in total proceeds. The transactions were carried out on May 22, 2024, and reported in a filing with the Securities and Exchange Commission the following day.
According to the SEC filing, Kool sold a total of 4,470 shares of Aspen Aerogels common stock at a weighted average price of $27.30. The total value of the shares sold amounted to approximately $122,031. This sale was executed in multiple trades, and the specific details of each trade, including the number of shares sold, are available upon request.
Additionally, on the same date, Kool acquired 4,470 shares of common stock through the exercise of stock options at a price of $12.15 per share. The total value of these acquired shares was about $54,310. It is important to note that the options exercised are fully vested and exercisable, as indicated in the filing.
Following these transactions, the SEC filing notes that Kool still owns 11,685 shares of Aspen Aerogels common stock directly, which includes 7,488 shares of restricted stock.
Investors often monitor insider transactions as they provide insights into executives’ confidence in the company's future performance. Transactions by directors, in particular, are closely watched as they may reflect the sentiment of the company's leadership.
Aspen Aerogels specializes in providing thermal management and energy conservation solutions, with a range of products that serve various industries, including construction and energy.
Investors and shareholders can access full details of the transactions by contacting the Securities and Exchange Commission, Aspen Aerogels, or through a direct request to the reporting person.
InvestingPro Insights
Following the recent insider transactions at Aspen Aerogels Inc (NYSE:ASPN), investors are keen to understand the company's financial health and prospects. With a market capitalization of approximately $2.1 billion USD, Aspen Aerogels shows a significant presence in its industry. Despite a negative P/E ratio of -63.41, reflecting challenges in profitability over the last twelve months, the company's revenue growth has been robust. In the last twelve months as of Q1 2024, revenue growth was an impressive 53.37%, with an even more remarkable quarterly revenue growth rate of 107.3% in Q1 2024. The gross profit margin stands at a healthy 31.39%, signaling effective cost management relative to revenue.
InvestingPro Tips suggest that Aspen Aerogels is expected to see net income growth and sales growth in the current year, which aligns with the strong revenue growth figures. Analysts have revised their earnings upwards for the upcoming period, indicating potential optimism about the company's future performance. Moreover, the company's stock has experienced a high return over the last year, with a total price return of 293.6%, and is trading near its 52-week high, at 98.71% of the peak price.
For those looking to delve deeper into Aspen Aerogels' financials and future outlook, InvestingPro offers an array of additional tips, such as the company's liquidity position, debt levels, and profitability predictions for the year. In fact, there are 17 additional InvestingPro Tips available for Aspen Aerogels Inc, which can be accessed by visiting: https://www.investing.com/pro/ASPN. To enhance your investing strategy, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.